MAB7225
Bromodeoxyuridine/BrdU Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MAB7225-Each-of-1 | In Stock | ₹ 45,004.56 |
MAB7225 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 45,004.56
GST (18%): ₹ 8,100.821
Total Price: ₹ 53,105.381
Antigen
Bromodeoxyuridine/BrdU
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species
Mouse
Purification Method
Protein A or G purified from hybridoma culture supernatant
Regulatory Status
RUO
Test Specificity
Detects Bromodeoxyuridine/BrdU.
Target Species
Multi-species
Form
Purified
Applications
Immunohistochemistry, Flow Cytometry, Immunocytochemistry, CyTOF
Clone
BU-1
Dilution
Immunohistochemistry 1-25 ug/mL, Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready
Gene Alias
5-bromo-2-deoxyuridine, BrdU, Bromodeoxyuridine, BUdr
Immunogen
5-iodourindine (5-IO) coupled to ovalbumin
Quantity
100 μg
Primary or Secondary
Primary
Reconstitution
Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype
IgG2a
Related Products
Description
- Bromodeoxyuridine/BrdU Monoclonal specifically detects Bromodeoxyuridine/BrdU in Multi-Species samples
- It is validated for Immunohistochemistry, Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready.
Compare Similar Items
Show Difference
Antigen: Bromodeoxyuridine/BrdU
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Test Specificity: Detects Bromodeoxyuridine/BrdU.
Target Species: Multi-species
Form: Purified
Applications: Immunohistochemistry, Flow Cytometry, Immunocytochemistry, CyTOF
Clone: BU-1
Dilution: Immunohistochemistry 1-25 ug/mL, Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready
Gene Alias: 5-bromo-2-deoxyuridine, BrdU, Bromodeoxyuridine, BUdr
Immunogen: 5-iodourindine (5-IO) coupled to ovalbumin
Quantity: 100 μg
Primary or Secondary: Primary
Reconstitution: Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG2a
Antigen:
Bromodeoxyuridine/BrdU
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Test Specificity:
Detects Bromodeoxyuridine/BrdU.
Target Species:
Multi-species
Form:
Purified
Applications:
Immunohistochemistry, Flow Cytometry, Immunocytochemistry, CyTOF
Clone:
BU-1
Dilution:
Immunohistochemistry 1-25 ug/mL, Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready
Gene Alias:
5-bromo-2-deoxyuridine, BrdU, Bromodeoxyuridine, BUdr
Immunogen:
5-iodourindine (5-IO) coupled to ovalbumin
Quantity:
100 μg
Primary or Secondary:
Primary
Reconstitution:
Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG2a
Antigen: Bromodeoxyuridine/BrdU
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Test Specificity: Detects Bromodeoxyuridine/BrdU.
Target Species: Multi-species
Form: Purified
Applications: Immunohistochemistry, Flow Cytometry, Immunocytochemistry, CyTOF
Clone: BU-1
Dilution: Immunohistochemistry 1-25 ug/mL, Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready
Gene Alias: 5-bromo-2-deoxyuridine, BrdU, Bromodeoxyuridine, BUdr
Immunogen: 5-iodourindine (5-IO) coupled to ovalbumin
Quantity: 25 μg
Primary or Secondary: Primary
Reconstitution: Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG2a
Antigen:
Bromodeoxyuridine/BrdU
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Test Specificity:
Detects Bromodeoxyuridine/BrdU.
Target Species:
Multi-species
Form:
Purified
Applications:
Immunohistochemistry, Flow Cytometry, Immunocytochemistry, CyTOF
Clone:
BU-1
Dilution:
Immunohistochemistry 1-25 ug/mL, Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready
Gene Alias:
5-bromo-2-deoxyuridine, BrdU, Bromodeoxyuridine, BUdr
Immunogen:
5-iodourindine (5-IO) coupled to ovalbumin
Quantity:
25 μg
Primary or Secondary:
Primary
Reconstitution:
Sterile PBS to a final concentration of 0.5 mg/mL.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG2a
Antigen: RelA/NFkB p65
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with Sodium Azide
Host Species: Rabbit
Purification Method: Protein A or G purified from cell culture supernatant
Regulatory Status: RUO
Test Specificity: Detects human RelA/NF kappa B p65 when phosphorylated at S536.
Target Species: Human
Form: Purified
Applications: Western Blot, Immunocytochemistry
Clone: 1091B
Dilution: Western Blot 0.1 ug/mL, Simple Western 1 ug/mL, Immunocytochemistry 5-25 ug/mL
Gene Alias: MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65, p65, p65RelA, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65
Immunogen: Phosphopeptide containing the RelA/NF kappa B p65 S536 site
Quantity: 100 μg
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG
Antigen:
RelA/NFkB p65
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with Sodium Azide
Host Species:
Rabbit
Purification Method:
Protein A or G purified from cell culture supernatant
Regulatory Status:
RUO
Test Specificity:
Detects human RelA/NF kappa B p65 when phosphorylated at S536.
Target Species:
Human
Form:
Purified
Applications:
Western Blot, Immunocytochemistry
Clone:
1091B
Dilution:
Western Blot 0.1 ug/mL, Simple Western 1 ug/mL, Immunocytochemistry 5-25 ug/mL
Gene Alias:
MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65, p65, p65RelA, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65
Immunogen:
Phosphopeptide containing the RelA/NF kappa B p65 S536 site
Quantity:
100 μg
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG
Antigen: RelA/NFkB p65
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with Sodium Azide
Host Species: Rabbit
Purification Method: Protein A or G purified from cell culture supernatant
Regulatory Status: RUO
Test Specificity: Detects human RelA/NF kappa B p65 when phosphorylated at S536.
Target Species: Human
Form: Purified
Applications: Western Blot, Immunocytochemistry
Clone: 1091B
Dilution: Western Blot 0.1 ug/mL, Simple Western 1 ug/mL, Immunocytochemistry 5-25 ug/mL
Gene Alias: MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65, p65, p65RelA, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65
Immunogen: Phosphopeptide containing the RelA/NF kappa B p65 S536 site
Quantity: 25 μg
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG
Antigen:
RelA/NFkB p65
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with Sodium Azide
Host Species:
Rabbit
Purification Method:
Protein A or G purified from cell culture supernatant
Regulatory Status:
RUO
Test Specificity:
Detects human RelA/NF kappa B p65 when phosphorylated at S536.
Target Species:
Human
Form:
Purified
Applications:
Western Blot, Immunocytochemistry
Clone:
1091B
Dilution:
Western Blot 0.1 ug/mL, Simple Western 1 ug/mL, Immunocytochemistry 5-25 ug/mL
Gene Alias:
MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3transcription factor p65, p65, p65RelA, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65
Immunogen:
Phosphopeptide containing the RelA/NF kappa B p65 S536 site
Quantity:
25 μg
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG